CLINICAL_TRIALS trial_result · 2020-11-23

Clinical Trial Update: Safety and Effectiveness of EN3835 in the Treatment of EFP in Women [Phase 2]

View source ↗

Summary

Phase 2 trial update on EN3835 for Edematous Fibrosclerotic Panniculopathy and cellulite shows completed status with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

Snippet

Sponsor: Endo Pharmaceuticals | Conditions: Edematous Fibrosclerotic Panniculopathy, Cellulite | Phase 2 | Status: COMPLETED | Results posted: 2020-11-23